Research map: Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023

Back to the article

Papers in this map

  1. An Introduction to the Bootstrap · Bradley Efron · 1994 · 40000 citations · Cited by this paper
  2. Burden of cardiovascular diseases in the Asia–Pacific region from 1990 to 2023, with forecasts to 2050: a secondary analysis of the Global Burden of disease study 2023 · Nicholas Chew · 2026 · Cites this paper
  3. Dynamic regulation of circulating endotrophin by changes in fat mass in humans · 2026 · Related
  4. Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models · Simon N. Wood · 2010 · 7848 citations · Cited by this paper
  5. Cytochrome P450 2E1 deficiency alters hepatic mitochondria and impairs liver organoid formation · 2026 · Related
  6. Another look at measures of forecast accuracy · Rob J. Hyndman · 2006 · 5707 citations · Cited by this paper
  7. Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3 · 2026 · Related
  8. Automatic Time Series Forecasting: The forecast Package for R · Rob J. Hyndman · 2008 · 3588 citations · Cited by this paper
  9. Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis · 2026 · Related
  10. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends · Moien AB Khan · 2019 · 3247 citations · Cited by this paper
  11. GLP-1 Receptor Agonists and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction · 2026 · Related
  12. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 · Mohsen Naghavi · 2024 · 2816 citations · Cited by this paper
  13. Long-term prognosis of coexistent metabolic dysfunction–associated steatotic liver disease and chronic kidney disease following acute myocardial infarction · 2026 · Related
  14. The burden of disease in older people and implications for health policy and practice · Martin James Prince · 2014 · 2368 citations · Cited by this paper
  15. Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the US · 2026 · Related
  16. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  17. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis · Stephen A. Harrison · 2024 · 1982 citations · Cited by this paper
  18. Global Burden of Cardiovascular Diseases and Risks, 1990-2022 · George A. Mensah · 2023 · 1654 citations · Cited by this paper
  19. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association · Chiadi E. Ndumele · 2023 · 1330 citations · Cited by this paper
  20. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 · Marie Ng · 2025 · 1083 citations · Cited by this paper
  21. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 · Stein Emil Vollset · 2024 · 1046 citations · Cited by this paper
  22. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials · Colin Baigent · 2022 · 1023 citations · Cited by this paper
  23. Notes on the use of propagation of error formulas · H. H. Ku · 1966 · 981 citations · Cited by this paper
  24. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications · Giovanni Targher · 2024 · 882 citations · Cited by this paper
  25. Schools and Obesity Prevention: Creating School Environments and Policies to Promote Healthy Eating and Physical Activity · Mary T. Story · 2009 · 841 citations · Cited by this paper
  26. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · Simon I Hay · 2025 · 777 citations · Cited by this paper
  27. Global burden of cardiovascular diseases: projections from 2025 to 2050 · Bryan Chong · 2024 · 768 citations · Cited by this paper
  28. Multimorbidity and quality of life: Systematic literature review and meta-analysis · Tatjana T. Makovski · 2019 · 751 citations · Cited by this paper
  29. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors · João Leonardo Silveira Rossi · 2021 · 614 citations · Cited by this paper
  30. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 · Benjamin A. Stark · 2025 · 612 citations · Cited by this paper
  31. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · Mohsen Naghavi · 2025 · 508 citations · Cited by this paper
  32. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 · Jessica A Kerr · 2025 · 443 citations · Cited by this paper
  33. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 · Patrick B Mark · 2025 · 378 citations · Cited by this paper
  34. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials · Sunil V. Badve · 2024 · 332 citations · Cited by this paper
  35. Global burden of CVD: focus on secondary prevention of cardiovascular disease · Sameer Bansilal · 2015 · 295 citations · Cited by this paper
  36. Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All · Deborah Bartz · 2020 · 242 citations · Cited by this paper
  37. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis · Paschalis Karakasis · 2024 · 205 citations · Cited by this paper
  38. Impact of different ectopic fat depots on cardiovascular and metabolic diseases · Daniele Ferrara · 2019 · 198 citations · Cited by this paper
  39. The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019 · Bryan Chong · 2023 · 170 citations · Cited by this paper

Source: OpenAlex (CC0)